These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 20355180

  • 1. Proteolysis and autolysis of proteases and the detection of degradation products in doping control.
    Thomas A, Kohler M, Walpurgis K, Schänzer W, Thevis M.
    Drug Test Anal; 2009 Feb; 1(2):81-6. PubMed ID: 20355180
    [Abstract] [Full Text] [Related]

  • 2. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
    Thomas A, Kohler M, Schänzer W, Kamber M, Delahaut P, Thevis M.
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
    [Abstract] [Full Text] [Related]

  • 3. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS.
    Thomas A, Kohler M, Schänzer W, Delahaut P, Thevis M.
    Analyst; 2011 Mar 07; 136(5):1003-12. PubMed ID: 21157622
    [Abstract] [Full Text] [Related]

  • 4. Proteases in doping control analysis.
    Thevis M, Maurer J, Kohler M, Geyer H, Schänzer W.
    Int J Sports Med; 2007 Jul 07; 28(7):545-9. PubMed ID: 17525883
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A, Geyer H, Kamber M, Schänzer W, Thevis M.
    J Mass Spectrom; 2008 Jul 07; 43(7):908-15. PubMed ID: 18563864
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls.
    Thomas A, Walpurgis K, Delahaut P, Kohler M, Schänzer W, Thevis M.
    Drug Test Anal; 2013 Jul 07; 5(11-12):853-60. PubMed ID: 23913913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A, Höppner S, Geyer H, Schänzer W, Petrou M, Kwiatkowska D, Pokrywka A, Thevis M.
    Anal Bioanal Chem; 2011 Aug 07; 401(2):507-16. PubMed ID: 21298258
    [Abstract] [Full Text] [Related]

  • 13. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M.
    Drug Test Anal; 2013 Aug 07; 5(11-12):810-8. PubMed ID: 23873860
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
    Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M.
    Eur J Mass Spectrom (Chichester); 2012 Aug 07; 18(4):407-12. PubMed ID: 22971699
    [Abstract] [Full Text] [Related]

  • 18. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
    Thevis M, Guddat S, Schänzer W.
    Steroids; 2009 Mar 07; 74(3):315-21. PubMed ID: 19007801
    [Abstract] [Full Text] [Related]

  • 19. Urine analysis concerning xenon for doping control purposes.
    Thevis M, Piper T, Geyer H, Schaefer MS, Schneemann J, Kienbaum P, Schänzer W.
    Rapid Commun Mass Spectrom; 2015 Jan 15; 29(1):61-6. PubMed ID: 25462364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.